Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Larotaxel + Cisplatin vs Gemcitabine + Cisplatin in Advanced Urothelial Cancer
NCT00625664Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2008
- Primary completion
- Feb 2011
- Countries
- 19
01
Overview
A Phase 3 trial of larotaxel in bladder cancer, urothelial carcinoma (UC), sponsored by Sanofi. Started Feb 2008; status: completed.
02
Drugs
larotaxel
03
Conditions
bladder cancerurothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00625664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625664.